Watchful waiting or watchful progression

作者: Duncan B. McLaren , Michael McKenzie , Graeme Duncan , Tom Pickles

DOI: 10.1002/(SICI)1097-0142(19980115)82:2<349::AID-CNCR15>3.0.CO;2-Z

关键词: Tumor progressionProstate-specific antigenSurgeryMedicineRectal examinationPast medical historyStage (cooking)Watchful waitingPopulationInternal medicineMedical history

摘要: BACKGROUND Prostate specific antigen doubling time (PSAdt) is a dynamic model of prostate tumor biology. It predicts aggressive disease and subsequent clinical recurrence after radical treatment. However, as yet there only limited evidence for its validity in the watchful waiting population. METHODS One hundred thirteen previously untreated patients with adenocarcinoma who were referred to British Columbia Cancer Agency management opinion subsequently placed into prospective program. The reasons waiting, previous medical history, serial PSA, histopathologic data recorded. RESULTS The median age was 75 years (range, 49-85 years). follow-up from first appointment 14 months 0-58 months). correlated highly T classification (P = 0.003) past history 0.002). Approximately 40% T1 51% T2 had progression by 2 years, increasing 60% at 3 years. On multivariate analysis PSAdt strongly < 0.0001), stage 0.01), treatment 0.0001); grade initial not found be predictive any endpoints studied. Initial PSA significant predicting 0.03). 50% <18 progressed within 6 months. At last follow-up, no deaths carcinoma been recorded. Overall survival 5 92% 68%, respectively. CONCLUSIONS Using digital rectal examination, findings this study demonstrated high rates population. rather than standard criteria most powerful indicator activity. 1998;82:342-8. © 1998 American Society.

参考文章(17)
R. Sadasivan, R. Morgan, S. Jennings, M. Austenfeld, P. Van veldhuizen, R. Stephens, M. Noble, Overexpression of Her-2/Neu may be an Indicator of Poor Prognosis in Prostate Cancer The Journal of Urology. ,vol. 150, pp. 126- 131 ,(1993) , 10.1016/S0022-5347(17)35413-7
Hisashi Matsushima, Yoshio Hosaka, Makoto Suzuki, Takashi Mizutani, Hideshi Ishizuka, Kazuki Kawabe, bcl‐2 Expression in Prostate Cancer and its Relationship to Cell Cycle and Prognosis International Journal of Urology. ,vol. 3, pp. 113- 117 ,(1996) , 10.1111/J.1442-2042.1996.TB00494.X
Gerald E. Hanks, Alexandra L. Hanlon, W.Robert Lee, Anne Slivjak, Timothy E. Schultheiss, Pretreatment prostate-specific antigen doubling times: clinical utility of this predictor of prostate cancer behavior International Journal of Radiation Oncology Biology Physics. ,vol. 34, pp. 549- 553 ,(1996) , 10.1016/0360-3016(95)02154-X
Gunar K. Zagars, Prostate-specific antigen as a prognostic factor for prostate cancer treated by external beam radiotherapy. International Journal of Radiation Oncology Biology Physics. ,vol. 23, pp. 47- 53 ,(1992) , 10.1016/0360-3016(92)90542-P
W.Robert Lee, Gerald E. Hanks, Benjamin W. Corn, Timothy E. Schultheiss, Observations of pretreatment prostate-specific antigen doubling time in 107 patients referred for definitive radiotherapy. International Journal of Radiation Oncology Biology Physics. ,vol. 31, pp. 21- 24 ,(1995) , 10.1016/0360-3016(94)00339-M
Alan Pollack, Gunar K. Zagars, Adel K. El-Naggar, Nicholas H.A. Terry, Relationship of tumor DNA-ploidy toserum prostate-specific antigen doubling time after radiotherapy for prostate cancer Urology. ,vol. 44, pp. 711- 718 ,(1994) , 10.1016/S0090-4295(94)80213-0
Alan W. Partin, Charles R. Pound, Jay D. Pearson, J. Quentin Clemens, Patricia K. Landis, Jonathan I. Epstein, H.Ballentine Carter, Patrick C. Walsh, Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases Urology. ,vol. 43, pp. 649- 659 ,(1994) , 10.1016/0090-4295(94)90180-5
Peter N. Brawn, Alberto G. Ayala, Andrew C. Von Eschenbach, David H. Hussey, Douglas E. Johnson, Histologic grading study of prostate adenocarcinoma: The development of a new system and comparison with other methods—A preliminary study Cancer. ,vol. 49, pp. 525- 532 ,(1982) , 10.1002/1097-0142(19820201)49:3<525::AID-CNCR2820490321>3.0.CO;2-M
John E. McNeal, Arnauld A. Villers, Elise A. Redwine, Fuad S. Freiha, Thomas A. Stamey, Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate Cancer. ,vol. 66, pp. 1225- 1233 ,(1990) , 10.1002/1097-0142(19900915)66:6<1225::AID-CNCR2820660624>3.0.CO;2-X